These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 29582448

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy of systemic sirolimus in the treatment of generalized lymphatic anomaly and Gorham-Stout disease.
    Ricci KW, Hammill AM, Mobberley-Schuman P, Nelson SC, Blatt J, Bender JLG, McCuaig CC, Synakiewicz A, Frieden IJ, Adams DM.
    Pediatr Blood Cancer; 2019 May; 66(5):e27614. PubMed ID: 30672136
    [Abstract] [Full Text] [Related]

  • 4. Treatment of superficial vascular anomalies with topical sirolimus: A multicenter case series.
    Dodds M, Tollefson M, Castelo-Soccio L, Garzon MC, Hogeling M, Hook K, Boull C, Maguiness S.
    Pediatr Dermatol; 2020 Mar; 37(2):272-277. PubMed ID: 31957126
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Sirolimus as treatment for 19 patients with refractory cervicofacial lymphatic malformation.
    Strychowsky JE, Rahbar R, O'Hare MJ, Irace AL, Padua H, Trenor CC.
    Laryngoscope; 2018 Jan; 128(1):269-276. PubMed ID: 28782106
    [Abstract] [Full Text] [Related]

  • 9. Pediatric case of acquired progressive lymphatic anomaly treated with sirolimus.
    Komamizu S, Ozeki M, Hayashi D, Endo S, Hori-Hirose Y, Sasaki S, Ohnishi H.
    Pediatr Int; 2023 Jan; 65(1):e15497. PubMed ID: 36749179
    [No Abstract] [Full Text] [Related]

  • 10. Sirolimus in the Treatment of Vascular Anomalies.
    Triana P, Dore M, Cerezo VN, Cervantes M, Sánchez AV, Ferrero MM, González MD, Lopez-Gutierrez JC.
    Eur J Pediatr Surg; 2017 Feb; 27(1):86-90. PubMed ID: 27723921
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Oral rapamycin: an alternative in children with complicated vascular abnormalities.
    Gómez Sánchez A, Redondo Sedano JV, Pérez Alonso V, Martí Carrera ME, Baro Fernández M, Palencia Pérez SI, Gallego Herrero MC, Gómez Fraile A, Delgado Muñoz MD.
    Cir Pediatr; 2020 Oct 01; 33(4):183-187. PubMed ID: 33016658
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. MRI for Response Assessment of Extensive Lymphatic Malformations in Children Treated With Sirolimus.
    Durand R, Reid JR, Belasco JB, Shellikeri S, Calle-Toro JS, Cahill AM, Srinivasan A.
    AJR Am J Roentgenol; 2021 Sep 01; 217(3):741-752. PubMed ID: 33405944
    [Abstract] [Full Text] [Related]

  • 16. Effectiveness of sirolimus in the treatment of complex lymphatic malformations: Single center report of 56 cases.
    Tian R, Liang Y, Zhang W, Wang J, Shan Y, Gao H, Xie C, Li J, Xu M, Gu S.
    J Pediatr Surg; 2020 Nov 01; 55(11):2454-2458. PubMed ID: 32044101
    [Abstract] [Full Text] [Related]

  • 17. Model-Informed individualized dosage regimen of sirolimus in pediatric patients with intractable lymphatic malformations.
    Liu B, Zhang X, Zhao Y, Xu X, Wang S, Wang X, Cheng X.
    Eur J Pharm Sci; 2024 Sep 01; 200():106837. PubMed ID: 38960206
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sirolimus in the treatment of kaposiform lymphangiomatosis.
    Zhou J, Yang K, Chen S, Ji Y.
    Orphanet J Rare Dis; 2021 Jun 08; 16(1):260. PubMed ID: 34103076
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.